Lanthanide Complex Indicators for Neutral Sugars & Cancer Biomarkers
LSU Reference: 0521
Inventors:
- Robert Strongin
- William Crowe
- Isiah Warner
Status:
- Under patent prosecution
Description:
- Water-soluble lanthanide complexes can detect neutral carbohydrates, differentiate gangliosides and discriminate the cancer biomarker LPA (lysophosphatidylic acid) over other biomolecules at physiological pH .
Applications:
- Neutral carbohydrate, ganglioside and lysophosphatidic acid (LPA) detection.
Advantages:
- Superior sensitivity and discrimination.
Abstract: We have developed lanthanide-based water-soluble salophene complexes that are useful in three important ways: (i) Detection of neutral carbohydrates while at physiologically-relevant pH; (ii) Selective detection of sialic-acid rich gangliosides, known cancer biomarkers; and (iii) Selective detection of lysophosphatidic acid (LPA), a potential early stage ovarian cancer biomarker, even in the presence of other phospholipids and related biomolecules. All three detection modes utilize well-established and widespread fluorescence detection to quantify results. We have overcome the long-standing problem of competitive binding by bulk water, which has until now necessitated a highly elevated, far-from-physiological pH environment for a useful extent of coordination and signal transduction to occur. We also avoid the impractically-long analytical chemistry sequence previously required to assay for LPA with a rapid, easy-to-use protocol that could easily be placed in an ordinary clinical diagnostic laboratory.
This page was last updated Friday, November 19, 2010
